Institutional
First Light Asset Management, LLC
CIK 0001600004
$1.12B
Reported AUM
35
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · First Light Asset Management, LLC · Q1 2026
AI · grounded in 13F
First Light Asset Management, LLC closed its position in IRON for a reduction of $41.5M. The fund also exited its holding in MDGL for $38.9M and trimmed its stake in VERA by 63.9%. On the buy side, the fund established new positions in TLSI for $20.3M and TECX for $20M. Additionally, it increased its share count in APGE by 102.4%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AXGN | AXOGEN INC | $42.80 | 0.97% | 291.94% | 110.11% | $132.6M | 11.88% | −1,230,558 | −23.5% |
| 2 | PVLA | PALVELLA THERAPEUTICS INC | $108.67 | -5.36% | 327.83% | -60.97% | $122.3M | 10.96% | +271,617 | +38.3% |
| 3 | NEO | NEOGENOMICS INC | $10.90 | -3.63% | 46.90% | -76.36% | $72.2M | 6.47% | −305,085 | −3.0% |
| 4 | SIBN | SI-BONE INC | $15.12 | 1.61% | -20.00% | -50.16% | $67.6M | 6.06% | +320,286 | +6.4% |
| 5 | CNTA | CENTESSA PHARMACEUTICALS LIMITED | $39.62 | -0.45% | 232.38% | 91.96% | $62.0M | 5.56% | −717,949 | −31.5% |
| 6 | APGE | APOGEE THERAPEUTICS INC | $86.92 | -4.38% | 112.10% | 278.90% | $48.5M | 4.35% | +291,693 | +102.4% |
| 7 | AMLX | AMYLYX PHARMACEUTICALS INC | $13.32 | -6.92% | 149.91% | -59.51% | $44.3M | 3.97% | −164,894 | −4.9% |
| 8 | TWST | TWIST BIOSCIENCE CORPORATION | $69.22 | -6.37% | 119.26% | -43.75% | $41.8M | 3.74% | −261,923 | −23.0% |
| 9 | CRNX | CRINETICS PHARMACEUTICALS INC | $32.92 | -4.94% | -0.27% | 83.09% | $39.6M | 3.55% | −104,593 | −8.8% |
| 10 | MASS | 908 DEVICES INC | $7.93 | -10.09% | 14.27% | -74.62% | $37.2M | 3.33% | +1,236,377 | +25.6% |
| 11 | NPCE | NEUROPACE INC | $15.74 | -3.55% | 19.70% | -26.10% | $32.3M | 2.90% | +1,110,484 | +82.3% |
| 12 | EWTX | EDGEWISE THERAPEUTICS INC | $35.59 | -4.41% | 133.53% | 103.26% | $31.6M | 2.83% | −571,855 | −36.3% |
| 13 | ANAB | ANAPTYS BIO INC | $50.37 | -2.52% | 218.80% | 228.79% | $31.4M | 2.81% | −80,807 | −12.5% |
| 14 | SLP | SIMULATIONS PLUS INC | $15.88 | -4.62% | -42.36% | -65.73% | $31.1M | 2.79% | +663,906 | +33.7% |
| 15 | GH | GUARDANT HEALTH | $125.61 | -5.60% | 161.36% | 14.40% | $25.9M | 2.32% | −14,452 | −4.9% |
| 16 | TNDM | TANDEM DIABETES CARE INC | $19.34 | -0.57% | -6.93% | -82.20% | $25.2M | 2.26% | +225,222 | +20.7% |
| 17 | ATRC | ATRICURE INC | $27.10 | -0.62% | -22.44% | -67.91% | $20.8M | 1.87% | −445,924 | −37.9% |
| 18 | TLSI | TRISALUS LIFE SCIENCES INC | $3.17 | -3.94% | -41.19% | -67.35% | $20.3M | 1.82% | +5,066,827 | NEW |
| 19 | TECX | TECTONIC THERAPEUTICS INC | $29.00 | -0.45% | 25.76% | -67.16% | $20.0M | 1.79% | +647,743 | NEW |
| 20 | IRTC | IRHYTHM TECHNOLOGIES | $108.11 | 0.70% | -26.30% | 111.47% | $19.8M | 1.78% | +14,245 | +9.3% |
| 21 | SEPN | SEPTERNA INC | $31.15 | -0.70% | 205.09% | 23.17% | $17.6M | 1.58% | +112,049 | +18.0% |
| 22 | ESTA | ESTABLISHMENT LABS HOLDINGS | $74.31 | -2.85% | 95.55% | -6.28% | $17.5M | 1.57% | −65,344 | −17.5% |
| 23 | HCAT | HEALTH CATALYST INC | $1.93 | -0.52% | -52.93% | -96.68% | $16.4M | 1.47% | −32,241 | −0.2% |
| 24 | OMCL | OMNICELL INC | $43.00 | -1.38% | 38.71% | -70.65% | $16.4M | 1.47% | +489,846 | NEW |
| 25 | KRMD | KORU MEDICAL SYSTEMS INC | $3.93 | -5.07% | 27.60% | 15.25% | $16.3M | 1.46% | −442,132 | −10.5% |
| 26 | WGS | GENEDX HOLDINGS CORP | $52.21 | -7.22% | -27.56% | -85.97% | $15.6M | 1.40% | +242,927 | NEW |
| 27 | WVE | WAVE LIFE SCIENCES LTD | $5.73 | -5.91% | -20.64% | 3.99% | $13.4M | 1.20% | −9,883 | −0.5% |
| 28 | VERA | VERA THERAPEUTICS INC | $32.29 | -3.27% | 42.25% | 79.39% | $12.6M | 1.13% | −555,770 | −63.9% |
| 29 | MDXG | MIMEDX GROUP INC | $3.74 | -1.06% | -42.37% | -69.49% | $11.2M | 1.01% | −196,449 | −6.5% |
| 30 | BFLY | BUTTERFLY NETWORK INC | $4.57 | -11.95% | 84.27% | -57.45% | $10.7M | 0.96% | −151,964 | −5.4% |
| 31 | SGP | SPYGLASS PHARMA INC | $18.78 | -3.54% | — | — | $9.7M | 0.87% | +375,000 | NEW |
| 32 | ORGO | ORGANOGENESIS HOLDINGS INC | $2.42 | -2.42% | — | — | $8.3M | 0.74% | −364,287 | −9.4% |
| 33 | PCVX | VAXCYTE INC | $47.36 | -2.87% | — | — | $8.2M | 0.74% | +141,784 | NEW |
| 34 | ELVN | ENLIVEN THERAPEUTICS INC | $34.71 | -2.20% | — | — | $7.9M | 0.71% | +201,867 | NEW |
| 35 | RYTM | RHYTHM PHARMACEUTICALS INC | $86.40 | -1.38% | — | — | $7.6M | 0.68% | −208,663 | −70.5% |
| 36 | IRON | DISC MEDICINE INC | $67.00 | -5.78% | — | — | — | — | −523,167 | EXITED |
| 37 | MDGL | MADRIGAL PHARMACEUTICALS INC | $486.98 | -1.19% | — | — | — | — | −66,831 | EXITED |
| 38 | ABVX | ABIVAX SA-ADR | $101.53 | -3.24% | — | — | — | — | −88,674 | EXITED |
| 39 | DYN | DYNE THERAPEUTICS INC | $17.04 | -7.44% | — | — | — | — | −155,231 | EXITED |
| 40 | IWO | ISHARES RUSSELL 2000 GROWTH ETF | $366.27 | -4.34% | — | — | — | — | −760 | EXITED |
Source: SEC EDGAR · accession 0001999371-26-010896. 13F discloses long positions only — shorts, foreign equities, and options are excluded.